Brand name · Neuroactive Steroid

BRLIZIO

BRLIZIO is a brand name for LPCN 1154 (oral brexanolone), developed by Lipocine Inc..

Status: Phase 3 for Postpartum depression
Mechanism: GABA-A receptor PAM
Developer: Lipocine Inc.

Programs

LPCN 1154 (oral brexanolone) for Postpartum depressionPhase 3Active

Also known as

LPCN 1154
LPCN 1154A
brexanolone
oral brexanolone
allopregnanolone
3alpha,5alpha-tetrahydroprogesterone
516-54-1
3alpha-hydroxy-5alpha-pregnan-20-one

View the full LPCN 1154 (oral brexanolone) profile →